ReviewExperimental hematology & oncology2023
Targeting CD22 for B-cell hematologic malignancies.
Jia Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it
ReviewExperimental hematology & oncology2023
Jia Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.